X4 Pharmaceuticals Inc.

AI Score

XX

Unlock

0.22
-0.02 (-6.94%)
At close: Apr 01, 2025, 3:59 PM
0.22
-0.50%
After-hours: Apr 01, 2025, 07:55 PM EDT

X4 Pharmaceuticals Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 55.7M 99.22M 121.72M 81.79M 78.71M
Short-Term Investments 46.36M 15M n/a n/a n/a
Long-Term Investments n/a n/a 1.02M 1.32M 1.73M
Other Long-Term Assets 2.08M 1.44M 1.23M 1.72M 3.26M
Receivables 1.71M 562K 1.15M 747K 917K
Inventory 2.82M n/a n/a n/a n/a
Other Current Assets 6.23M 7.3M 5.81M n/a n/a
Total Current Assets 112.17M 122.08M 128.68M 87.88M 83.31M
Property-Plant & Equipment 4.84M 6.39M 8.33M 10.22M 9.2M
Goodwill & Intangibles 27.35M 17.35M 17.35M 17.35M 27.11M
Total Long-Term Assets 34.27M 25.18M 26.91M 29.3M 39.56M
Total Assets 146.45M 147.26M 155.59M 117.18M 122.87M
Account Payables 8.62M 8.95M 7.78M 4.28M 3.14M
Deferred Revenue n/a n/a n/a n/a n/a
Short-Term Debt 1.25M n/a 2.51M 1.87M 786K
Other Current Liabilities 13.05M 8.2M 5.39M 4.34M 3.48M
Total Current Liabilities 32.88M 22.86M 22.32M 14.02M 11.95M
Long-Term Debt 1.41M 54.57M 32.3M 33.14M 33.18M
Other Long-Term Liabilities 88.6M 16.11M 23.3M 826K 462K
Total Long-Term Liabilities 91.42M 73.3M 59.21M 38.74M 38.12M
Total Liabilities 124.3M 96.16M 81.53M 52.76M 50.07M
Total Debt 2.66M 58.28M 38.42M 39.78M 38.45M
Common Stock 171K 167K 122K 28K 16K
Retained Earnings -515.36M -477.9M -376.74M -282.87M -194.18M
Comprehensive Income -122K -119K -119K -119K -119K
Shareholders Equity 22.15M 51.1M 74.05M 64.41M 72.8M
Total Investments 46.36M 15M 1.02M 1.32M 1.73M